EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

3D PRINTING OF PERSONALIZED ORAL SOLID DOSAGE FORMS: FORMULATION STRATEGIES, CLINICAL DRIVERS, AND TRANSLATIONAL CHALLENGES

Niroop Lakkapatri, Dr. Rajesh Vooturi, Veena Vithalapuram, Raju Eddagiri

Journal of Applied Pharmaceutical Sciences and Research · 15.04.2026 · 9 (1) · 1-9

DOI: 10.31069/japsr/v9i1.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Sciences and Research, online erschienen am 15.04.2026. Verfasst von Niroop Lakkapatri und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over the past decade, additive manufacturing has enabled on-demand fabrication of patient-specific oral solid dosage forms in which dose, geometry and internal architecture are programmed from a digital design—capabilities conventional batch tableting cannot readily deliver. Scope & Approach: This review critically examines formulation strategies underlying the development of 3D-printed personalized OSDs, with emphasis on material selection, printability, drug–polymer interactions and the impact of processing parameters on critical quality attributes, including content uniformity, mechanical integrity, and drug release performance. Clinical Drivers: Clinical needs for personalization—such as pediatric and geriatric dosing, narrow therapeutic index drugs and scenarios requiring patient-specific release profiles—are summarized to highlight unmet therapeutic needs. Key Findings: Advances in fused deposition modeling, semi-solid extrusion, binder jetting and inkjet printing are evaluated in the context of formulation flexibility and translational feasibility.

Conclusions

Despite substantial progress, clinical implementation remains constrained by regulatory uncertainty, scalability–personalization trade-offs, quality assurance requirements and stability considerations. Future opportunities integrating QbD, PAT and digital design tools are discussed as enablers for robust, regulatory-compliant translation of personalized 3D-printed OSDs into clinical practice.

Zitieren

APA

Lakkapatri, N., Vooturi, D. R., Vithalapuram, V., & Eddagiri, R. (2026). 3D PRINTING OF PERSONALIZED ORAL SOLID DOSAGE FORMS: FORMULATION STRATEGIES, CLINICAL DRIVERS, AND TRANSLATIONAL CHALLENGES. Journal of Applied Pharmaceutical Sciences and Research, 9(1), 1-9. https://doi.org/10.31069/japsr/v9i1.01

Vancouver

Lakkapatri N, Vooturi DR, Vithalapuram V, Eddagiri R. 3D PRINTING OF PERSONALIZED ORAL SOLID DOSAGE FORMS: FORMULATION STRATEGIES, CLINICAL DRIVERS, AND TRANSLATIONAL CHALLENGES. Journal of Applied Pharmaceutical Sciences and Research. 2026;9(1):1-9. doi:10.31069/japsr/v9i1.01

BibTeX
@article{Lakkapatri2026,
  author = {Lakkapatri, Niroop and Vooturi, Dr. Rajesh and Vithalapuram, Veena and Eddagiri, Raju},
  title = {3D PRINTING OF PERSONALIZED ORAL SOLID DOSAGE FORMS: FORMULATION STRATEGIES, CLINICAL DRIVERS, AND TRANSLATIONAL CHALLENGES},
  journal = {Journal of Applied Pharmaceutical Sciences and Research},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1--9},
  doi = {10.31069/japsr/v9i1.01}
}
Kostenlos starten →